نام دارو: Brilinta شكل دارو:قرص
تاریخ تصویب : July 20, 2011
شرکت : AstraZeneca
Brilinta is used to lower your chance of having a heart attack or dying from a heart attack or stroke but Brilinta (and similar drugs) can cause bleeding that can be serious and sometimes lead to death. In cases of serious bleeding, such as internal bleeding, the bleeding may result in the need for blood transfusions or surgery. While you take Brilinta:
- you may bruise and bleed more easily
- you are more likely to have nose bleeds
- it will take longer than usual for any bleeding to stop
Call your doctor right away, if you have any of these signs or symptoms of bleeding while taking Brilinta:
- bleeding that is severe or that you cannot control
- pink, red or brown urine
- vomiting blood or your vomit looks like “coffee grounds”
- red or black stools (looks like tar)
- coughing up blood or blood clots
Do not stop taking Brilinta without talking to the doctor who prescribes it for you. People who are treated with a stent, and stop taking Brilinta too soon, have a higher risk of getting a blood clot in the stent, having a heart attack, or dying. If you stop Brilinta because of bleeding, or for other reasons, your risk of a heart attack or stroke may increase.
When instructed by your doctor, you should stop taking Brilinta 5 days before you have elective surgery. This will help to decrease your risk of bleeding with your surgery or procedure. Your doctor should tell you when to start taking Brilinta again, as soon as possible after surgery.
